NASDAQ:STAA - STAAR Surgical Stock Price, Forecast & News

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

STAAR Surgical (NASDAQ:STAA) released its quarterly earnings data on Wednesday, October, 30th. The medical instruments supplier reported $0.05 EPS for the quarter, hitting analysts' consensus estimates of $0.05. The medical instruments supplier had revenue of $39.06 million for the quarter, compared to the consensus estimate of $37.50 million. STAAR Surgical had a return on equity of 13.84% and a net margin of 6.15%. View STAAR Surgical's Earnings History.

STAAR Surgical is scheduled to release their next quarterly earnings announcement on Thursday, February 20th 2020. View Earnings Estimates for STAAR Surgical.

STAAR Surgical updated its FY 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $150.2-150.2 million, compared to the consensus revenue estimate of $149.45 million.

3 brokers have issued 12-month price objectives for STAAR Surgical's stock. Their forecasts range from $45.00 to $56.00. On average, they expect STAAR Surgical's share price to reach $49.00 in the next year. This suggests a possible upside of 31.9% from the stock's current price. View Analyst Price Targets for STAAR Surgical.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STAAR Surgical.

Media stories about STAA stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. STAAR Surgical earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave media headlines about the medical instruments supplier a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the immediate future. View News Stories for STAAR Surgical.

STAAR Surgical saw a decrease in short interest during the month of December. As of December 31st, there was short interest totalling 3,950,000 shares, a decrease of 7.7% from the December 15th total of 4,280,000 shares. Based on an average trading volume of 373,500 shares, the short-interest ratio is presently 10.6 days. Approximately 9.0% of the shares of the stock are short sold. View STAAR Surgical's Current Options Chain.

Some companies that are related to STAAR Surgical include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Quidel (QDEL), Merit Medical Systems (MMSI), Atrion (ATRI), Antares Pharma (ATRS), Cerus (CERS), Anika Therapeutics (ANIK), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include NVIDIA (NVDA), Rockwell Medical (RMTI), Vanda Pharmaceuticals (VNDA), Xilinx (XLNX), Verizon Communications (VZ), TransEnterix (TRXC), Sorrento Therapeutics (SRNE), Veracyte (VCYT), vTv Therapeutics (VTVT) and Walt Disney (DIS).

STAAR Surgical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include KAMES CAPITAL plc (0.24%), California Public Employees Retirement System (0.21%), Assenagon Asset Management S.A. (0.03%), BosValen Asset Management Ltd (0.03%), NEXT Financial Group Inc (0.01%) and Exchange Traded Concepts LLC (0.01%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Jon K Hayashida, Keith Holliday, Samuel J Gesten, Scott D Barnes and William P Wall. View Institutional Ownership Trends for STAAR Surgical.

STAA stock was sold by a variety of institutional investors in the last quarter, including BosValen Asset Management Ltd and KAMES CAPITAL plc. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Graydon C Hansen, Jon K Hayashida, Keith Holliday, Samuel J Gesten and Scott D Barnes. View Insider Buying and Selling for STAAR Surgical.

STAA stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., California Public Employees Retirement System, Exchange Traded Concepts LLC, TRUE Private Wealth Advisors and NEXT Financial Group Inc. View Insider Buying and Selling for STAAR Surgical.

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of STAA stock can currently be purchased for approximately $37.15.

STAAR Surgical has a market capitalization of $1.65 billion and generates $123.95 million in revenue each year. The medical instruments supplier earns $4.97 million in net income (profit) each year or $0.28 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.View Additional Information About STAAR Surgical.

The official website for STAAR Surgical is http://www.staar.com/.

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]